Using pharmacogenetics to improve drug safety and efficacy.
Publication
, Journal Article
Haga, SB; Burke, W
Published in: Jama
June 16, 2004
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Jama
DOI
EISSN
1538-3598
Publication Date
June 16, 2004
Volume
291
Issue
23
Start / End Page
2869 / 2871
Location
United States
Related Subject Headings
- Thioguanine
- Pharmacogenetics
- Pharmaceutical Preparations
- Methyltransferases
- Mercaptopurine
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxymethylglutaryl CoA Reductases
- Humans
- General & Internal Medicine
- Drug-Related Side Effects and Adverse Reactions
Citation
APA
Chicago
ICMJE
MLA
NLM
Haga, S. B., & Burke, W. (2004). Using pharmacogenetics to improve drug safety and efficacy. Jama, 291(23), 2869–2871. https://doi.org/10.1001/jama.291.23.2869
Haga, Susanne B., and Wylie Burke. “Using pharmacogenetics to improve drug safety and efficacy.” Jama 291, no. 23 (June 16, 2004): 2869–71. https://doi.org/10.1001/jama.291.23.2869.
Haga SB, Burke W. Using pharmacogenetics to improve drug safety and efficacy. Jama. 2004 Jun 16;291(23):2869–71.
Haga, Susanne B., and Wylie Burke. “Using pharmacogenetics to improve drug safety and efficacy.” Jama, vol. 291, no. 23, June 2004, pp. 2869–71. Pubmed, doi:10.1001/jama.291.23.2869.
Haga SB, Burke W. Using pharmacogenetics to improve drug safety and efficacy. Jama. 2004 Jun 16;291(23):2869–2871.
Published In
Jama
DOI
EISSN
1538-3598
Publication Date
June 16, 2004
Volume
291
Issue
23
Start / End Page
2869 / 2871
Location
United States
Related Subject Headings
- Thioguanine
- Pharmacogenetics
- Pharmaceutical Preparations
- Methyltransferases
- Mercaptopurine
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxymethylglutaryl CoA Reductases
- Humans
- General & Internal Medicine
- Drug-Related Side Effects and Adverse Reactions